ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 100 filers reported holding ADMA BIOLOGICS INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,488,749 | +122.3% | 2,929,818 | +129.2% | 0.00% | +50.0% |
Q2 2023 | $4,717,240 | +2466.4% | 1,278,385 | +2202.1% | 0.00% | – |
Q1 2023 | $183,807 | +85391.6% | 55,531 | 0.0% | 0.00% | – |
Q4 2022 | $215 | -99.8% | 55,531 | -4.6% | 0.00% | – |
Q3 2022 | $141,000 | +11.9% | 58,179 | -9.0% | 0.00% | – |
Q2 2022 | $126,000 | +18.9% | 63,962 | +10.9% | 0.00% | – |
Q1 2022 | $106,000 | +30.9% | 57,672 | 0.0% | 0.00% | – |
Q4 2021 | $81,000 | -30.8% | 57,672 | -44.1% | 0.00% | – |
Q3 2021 | $117,000 | -47.5% | 103,218 | -25.9% | 0.00% | – |
Q2 2021 | $223,000 | -16.5% | 139,313 | -8.2% | 0.00% | – |
Q1 2021 | $267,000 | +853.6% | 151,713 | +1181.4% | 0.00% | – |
Q3 2020 | $28,000 | -48.1% | 11,840 | -16.2% | 0.00% | – |
Q1 2019 | $54,000 | +58.8% | 14,127 | 0.0% | 0.00% | – |
Q4 2018 | $34,000 | – | 14,127 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |